Literature DB >> 27365140

Droplet digital PCR assay for quantifying of CALR mutant allelic burden in myeloproliferative neoplasms.

Luisa Anelli1, Antonella Zagaria1, Nicoletta Coccaro1, Giuseppina Tota1, Angela Minervini1, Paola Casieri1, Luciana Impera1, Crescenzio Francesco Minervini1, Claudia Brunetti1, Alessandra Ricco1, Paola Orsini1, Cosimo Cumbo1, Giorgina Specchia1, Francesco Albano2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27365140     DOI： 10.1007/s00277-016-2739-2

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  6 in total

Review 1.  Current and Emerging Applications of Droplet Digital PCR in Oncology.

Authors:  Susana Olmedillas-López; Mariano García-Arranz; Damián García-Olmo
Journal:  Mol Diagn Ther       Date:  2017-10       Impact factor: 4.074

Review 2.  Monitoring Minimal Residual Disease in the Myeloproliferative Neoplasms: Current Applications and Emerging Approaches.

Authors:  Karl Haslam; Stephen E Langabeer
Journal:  Biomed Res Int       Date:  2016-10-20       Impact factor: 3.411

3.  Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia.

Authors:  Angela Minervini; Crescenzio Francesco Minervini; Luisa Anelli; Antonella Zagaria; Paola Casieri; Nicoletta Coccaro; Cosimo Cumbo; Giuseppina Tota; Luciana Impera; Paola Orsini; Claudia Brunetti; Annamaria Giordano; Giorgina Specchia; Francesco Albano
Journal:  Oncotarget       Date:  2016-12-27

Review 4.  Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic Malignancies.

Authors:  Nicoletta Coccaro; Giuseppina Tota; Luisa Anelli; Antonella Zagaria; Giorgina Specchia; Francesco Albano
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

Review 5.  Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool.

Authors:  Sara Galimberti; Serena Balducci; Francesca Guerrini; Marzia Del Re; Rossella Cacciola
Journal:  Diagnostics (Basel)       Date:  2022-05-24

6.  Genomic BCR-ABL1 breakpoint characterization by a multi-strategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients.

Authors:  Cosimo Cumbo; Luciana Impera; Crescenzio Francesco Minervini; Paola Orsini; Luisa Anelli; Antonella Zagaria; Nicoletta Coccaro; Giuseppina Tota; Angela Minervini; Paola Casieri; Claudia Brunetti; Antonella Russo Rossi; Elisa Parciante; Giorgina Specchia; Francesco Albano
Journal:  Oncotarget       Date:  2018-01-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.